Silicon Valley Capital Partners Ark Genomic Revolution ETF (De Transaction History
Silicon Valley Capital Partners
- $1.06 Billion
- Q3 2025
A detailed history of Silicon Valley Capital Partners transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Silicon Valley Capital Partners holds 62 shares of ARKG stock, worth $1,667. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62
Previous 62
-0.0%
Holding current value
$1,667
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
296Shares Held
20.4MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio